The Expression of MGMT and ErbB2 in Human Glioma

被引：0
作者：
Sun Chun-ming [1 ]
Wang Zhi-min [1 ]
Zheng Shi-ying [2 ]
Xu Qi-nian [1 ]
Zhang Shi-ming [1 ]
Zhou Dai [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Cardio Thorac Surg, Suzhou 215006, Peoples R China
来源：
2009 INTERNATIONAL CONFERENCE ON FUTURE BIOMEDICAL INFORMATION ENGINEERING (FBIE 2009) | 2009年
关键词：
Glioma: Drug-resistance gene: RT-PCR; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; BREAST-CANCER; METHYLTRANSFERASE; CHEMOTHERAPY; CELLS; O-6-BENZYLGUANINE; RESISTANCE;
D O I：
10.1109/FBIE.2009.5405896
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
This study was comparison of MGMT and ERBB2 expression in human gliomas. RT-PCR method was used to determine the mRNA levels of MGMT and ErbB2 gene in 42 clinical glioma specimens,There was significant concordance between the expression of MGMT and ErbB2(p<0.01). MGMT and ErbB are highly remarkably related each other. The results suggest that there may be in relationship among MGMT and ErbB2 expression in human gliomas which affect DNA repair resulting in drug resistance.
引用
收藏
页码：253 / +
页数：2
相关论文
共 50 条
  • [31] Transcriptome changes induced by docetaxel in human mammary cell lines expressing different levels of ERBB2
    Dos Santos, M. L.
    Gimenes, K. P.
    Silva, W. A., Jr.
    Nagai, M. A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (06) : 733 - 743
  • [32] Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression
    Dos Santos, Mariana Lopes
    Palanch, Carolina Goncalves
    Salaorni, Sibeli
    Da Silva, Wilson Araujo, Jr.
    Nagai, Maria Aparecida
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (06) : 1441 - 1461
  • [33] Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta
    Panina, A. A.
    Rybchenko, V. S.
    Solopova, O. N.
    Balabashin, D. S.
    Yakimov, S. A.
    Aliev, T. K.
    Dolgikh, D. A.
    Sveshnikov, P. G.
    Kirpichnikov, M. P.
    ACTA NATURAE, 2020, 12 (02): : 95 - 104
  • [34] A way to invade A story of ErbB2 and lysosomes
    Rafn, Bo
    Kallunki, Tuula
    CELL CYCLE, 2012, 11 (13) : 2415 - 2416
  • [35] Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer
    O Stal
    L Akerberg
    B Nordenskjold
    B Olsson
    LE Rutqvist
    L Skoog
    Breast Cancer Research, 2 (Suppl 1)
  • [36] Quantification of Differential ErbB1 and ErbB2 Cell Surface Expression and Spatial Nanoclustering through Plasmon Coupling
    Wang, Jing
    Yu, Xinwei
    Boriskina, Svetlana V.
    Reinhard, Bjoern M.
    NANO LETTERS, 2012, 12 (06) : 3231 - 3237
  • [37] ErbB2 diagnostics in breast cancer - an update
    Rueschoff, J.
    Nagelmeier, I.
    Hofmann, M.
    Henkel, Th.
    Stoss, O.
    PATHOLOGE, 2009, 30 (02): : 147 - 155
  • [38] BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
    Miele, Evelina
    Abballe, Luana
    Spinelli, Gian Paolo
    Besharat, Zein Mersini
    Catanzaro, Giuseppina
    Chiacchiarini, Martina
    Vacca, Alessandra
    Po, Agnese
    Capalbo, Carlo
    Ferretti, Elisabetta
    BMC CANCER, 2020, 20 (01)
  • [39] Mechanisms of cardiotoxicity associated with ErbB2 inhibitors
    Fedele, Carmine
    Riccio, Gennaro
    Malara, Angela Eliana
    D'Alessio, Giuseppe
    De Lorenzo, Claudia
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 595 - 602
  • [40] The Cause of ErbB2 Receptor Resistance to Downregulation
    Shramova, E. I.
    Proshkina, G. M.
    Deyev, S. M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2018, 44 (03) : 279 - 288
12345